
Vir Biotechnology Hits Day Low of $5.87 Amid Price Pressure
2025-10-30 19:30:26Vir Biotechnology, Inc. has faced notable challenges, with a significant stock decline and ongoing financial struggles, including a net profit drop and negative cash flow. Over the past three years, the company has underperformed compared to the S&P 500, leading to reduced stakeholder confidence and a small-cap market capitalization.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






